Articles On Analytica (ASX:ALT)

By Tim Boreham, Editor ASX code: ((HYD)) Market cap: $4.3m Shares on issue: 254,218,847 Financials (December half 2023): revenue $5.97m (down -17.5%), loss of $3.82m (-$1.96m deficit previously), cash of $847,277 (down -73.5%)* * After bala...

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month   Steve Jobs used to say that the most...

In this week's Weekly Insights:-Healthy Health, Wealthy Wealth-August Results: Early Observations-Conviction Calls and Best Ideas-FNArena Talks (2x)By Rudi Filapek-Vandyck, Editor Healthy Health, Wealthy WealthHigher bond yields and a tough...

Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month   The world is anticipating a “game changer” as Brisba...

The ASX 200 climbed 0.86% today, after the RBA said it wants you all to get fired. Energy stocks climb 1.94% after I dared to turn my heater on this morning. Brightstar is thiiiis close to actual gold production, up 30% today as a result....

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May   There are clear signs the biotech sector is springing back to life after a disappointing 2...

Pfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of these weight loss drugs? Best and worst performing ASX biotechs over the past week   Earlier this week, Pfizer surprised the market by say...

The Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health and Telehealth also received significant funding allocations Here are the ASX stocks that could benefit   Medicare, telehealth and mental...

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

The battle between Facebook and the information commissioner continues. The battle between Facebook and the Office of the Australian Information Commissioner (OAIC) had a hearing in the High Court this week over the infamous Cambridge Analy...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Meta will trial a new subscription service for Facebook and Instagram users in Australia, at a cost of just under $25 per month. Meta CEO Mark Zuckerberg announced the trial of Meta Verified on Monday morning, with Australia and New Zealand...

Meta will trial a new subscription service for Facebook and Instagram users in Australia, at a cost of just under $25 per month. Meta CEO Mark Zuckerberg announced the trial of Meta Verified on Monday morning, with Australia and New Zealand...

The ASX 200 fell 0.21% and the ASX XEC slips 1.05% A 8 out of 11 sectors were lower led by Consumer Discretionary down 1.40% Energy sector and stocks rally after Russia announces plans to slash oil production   The ASX 200 dropped 0.21% t...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

RBA lifts rates 25 basis points, says there’s more where that came from ASX immediately sags 0.5% on news from the Reserve Bank Federal Court finds in favour of Nuix over former CEO’s $183 million claim   The ASX has had a choppy old day,...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The S&P ASX 200 rose 7.64%, in its best start to a year ever as global markets rally In a strong start to 2023 the S&P/ASX Emerging Companies index (XEC) rose ~8% in January Graphite explorer Lincoln Minerals soars more than 500% s...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX 200 rose up 0.57% but the ASX XEC slipped -0.08% A solid 8 out of 11 sectors were higher, with Materials leading the way ABS says high participation and low unemployment continues to reflect a tight labour market   The ASX 200 gai...

Audiences outraged over the benchmark’s “lacklustre, mediocre performance” today Standout winner Riedel Resources ends the day up by 50% on awesome assays FTX team drowning in irony as ‘hackers’ make off with more than $500 million   The...

ASX 200 holds steady around +0.8% since lunch Australian Pacific Coal CEO David Conry has left the company. Abruptly. Bain Capital making all the right noises about bringing Virgin back to the bourse   All up, it’s been a pretty tidy old...

Facebook's owner will pay $A1.1 billion in a lawsuit for allowing political consulting firm Cambridge Analytica to access data of as many as 87 million users.

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

The week that was You might’ve missed Friday in New York because it was Saturday in bed for us, but Wall Street took another tumble; all three major indices closed out their worst week since June an average ~5% lower. Yes, the hotter-than-e...

Small caps and benchmark down over 1% All sectors retreat on ill-winds blowing in from the states Tinkler is back   The ASX 200 has started a new week with its worst session since early July. While that can be pinned on a shift in US sent...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX 200 is up 0.6%, the XEC small caps index is down 0.8%  Tomorrow is RBA day, Wednesday is OPEC+ arvo We all should’ve bought into CBE last week, dammit    The local sharemarket is creeping quietly higher on Wednesday, with the reso...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

By now, most of us are aware social media companies collect vast amounts of our information. By doing this, they can target us with ads and monetise our attention. The latest chapter in the data-privacy debate concerns one of the world’s mo...

Little caps drive 1.5% higher, dragging benchmark beyond parity Central banks vs inflation episode #48: BoJ does nothing, BoE did nothing All action, no talk: Torque Metals spikes on no news Following a Wednesday night of fine, rich gains...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

Benchmark sags as Materials sector delivers even more tedious disappointment Coal miners hand back yesterday’s gains as investors tire of Chinese whispers Cannabis offers relief for investors and health stocks climb as well. The ASX has e...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

The ASX 200 and XEC small cap indices rise Attention turns to Tuesday’s date with RBA destiny Celsius Resources is hot   The ASX 200 and the Emerging Markets (XEC) indices are both trading higher on Monday up about 1.2%, ahead of tomorrow...

It wasn’t exactly a red-letter day for the market as a whole, though – the ASX adding less than 0.5%, in spite of a beckoning smile from Wall Street overnight. Aussie markets opened to the news that The Nasdaq had posted a 1.62% gain, follo...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Avita Medical makes spray on skin for burns and soft tissue injuries HITIQ’s concussion tech is popular for athletes and sports teams PainChek’s smartphone app can tell if babies or older Aussies are in pain There’s a plethora of biotech...

Emerging companies fall 0.7% ASX200 0.8% lower Superior Resources (ASX:SPQ) jumps on copper system find, Galileo up … heaps in May   The Emerging Companies (XEC) index is lower on Thursday, weighed down by broad losses as Credit Suisse a...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Google collects more personal data about its users than any other big tech company, an analysis has found just days after Facebook petitioned the ACCC for an exemption from regulation because Apple’s privacy crackdown is costing it money an...

Aussie small cap index falls flat, day two The ASX200 up 0.65% Conico is 50% higher   Rising gold prices and teetering tech stocks are playing dice for the soul of the ASX Emerging Companies (XEC) index on Wednesday, as the small cap top...

Mark Zuckerberg, head of Facebook-owner Meta, is being sued in the US over the Cambridge Analytica scandal that compromised the personal data of millions.

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX Small Cap index pops 1.4% rather nicely The top 200 ahead 1% AnteoTech and some clever diggers the big winners on Wednesday   The local small cap index is riding a mid-week mining boom with some standout individual performances from...

Today, Stockhead is having a bit of a moment. We’re just a couple of months shy of being a part of ASX small caps investors’ daily lives for five years. It’s hard to believe that since kicking off with all you need to know about Analytica’s...